bioMérieux and DIAGNOSTICS IS POWER at ECCMID 2018
Did you know bioMérieux’s at ECCMID stand N°3 this year? So why not see what’s trending on their stand and prepare ahead to make the most of your visit?
bioMérieux will be showcasing their extensive offer in Antimicrobial Stewardship (AMS). Experience how the power of diagnostics can help optimize antibiotic therapy – initiation, optimization and discontinuation.
And why not enjoy a coffee at one of the breaks while you enter their AMS Challenge to win a handy prize!
bioMérieux will also be hosting an Integrated Symposium on “Innovative Diagnostics in Microbiology: Real-World Impact on Patients” on Sunday April 22nd, 16:00-18:00 in Hall F, topics will include:
- The clinical impact of a routine molecular point-of-care testing strategy in adults presenting to hospital: the results of a large pragmatic randomized controlled trial
- Potentials and challenges of molecular diagnostics in HAP/VAP
- Value of combined biomarkers and rapid molecular tests in Pediatrics
- Diagnosing bloodstream infections what’s new?
Download the pdf invitation for more details: http://go.biomerieux.com/2018/eccmid/symposium
And don’t forget to follow them on Twitter during the congress to get regular updates #ECCMID2018.
Tags: Antibiotic Sensitivity, Blood Culture, Point of Care, Antibiotic Resistance, Antimicrobial Resistance Detection (ARD), Hospital Acquired Pneumonia (HAP/VAP)
Date Published: April 9, 2018
Source article link: bioMérieux (Clinical Diagnostics) » company contact details